Literature DB >> 29357123

Triglyceride Metabolism in the Liver.

Michele Alves-Bezerra1, David E Cohen1.   

Abstract

Triglyceride molecules represent the major form of storage and transport of fatty acids within cells and in the plasma. The liver is the central organ for fatty acid metabolism. Fatty acids accrue in liver by hepatocellular uptake from the plasma and by de novo biosynthesis. Fatty acids are eliminated by oxidation within the cell or by secretion into the plasma within triglyceride-rich very low-density lipoproteins. Notwithstanding high fluxes through these pathways, under normal circumstances the liver stores only small amounts of fatty acids as triglycerides. In the setting of overnutrition and obesity, hepatic fatty acid metabolism is altered, commonly leading to the accumulation of triglycerides within hepatocytes, and to a clinical condition known as nonalcoholic fatty liver disease (NAFLD). In this review, we describe the current understanding of fatty acid and triglyceride metabolism in the liver and its regulation in health and disease, identifying potential directions for future research. Advances in understanding the molecular mechanisms underlying the hepatic fat accumulation are critical to the development of targeted therapies for NAFLD. © 2018 American Physiological Society. Compr Physiol 8:1-22, 2018.
Copyright © 2018 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29357123      PMCID: PMC6376873          DOI: 10.1002/cphy.c170012

Source DB:  PubMed          Journal:  Compr Physiol        ISSN: 2040-4603            Impact factor:   9.090


  175 in total

1.  HCF-1 Regulates De Novo Lipogenesis through a Nutrient-Sensitive Complex with ChREBP.

Authors:  Elizabeth A Lane; Dong Wook Choi; Luisa Garcia-Haro; Zebulon G Levine; Meghan Tedoldi; Suzanne Walker; Nika N Danial
Journal:  Mol Cell       Date:  2019-06-18       Impact factor: 17.970

2.  Polar and neutral lipid composition of the copepod Lernaeocera lusci and its host Merluccius merluccius in relationship with the parasite intensity.

Authors:  Khaoula Telahigue; Imen Rabeh; Tarek Hajji; Rym Ben Ammar; Zied Mdaini; M'hamed El Cafsi; Ridha Ghali
Journal:  Parasitol Res       Date:  2021-05-14       Impact factor: 2.289

Review 3.  Research progress of ulinastatin in the treatment of liver diseases.

Authors:  Shangping Fang; Pengfei Li; Chenxu Zhu; Xiaoxiao Han; Pengju Bao; Wenjun Guo
Journal:  Int J Clin Exp Pathol       Date:  2020-11-01

4.  Lipid Metabolism and Immune Checkpoints.

Authors:  Qianjin Liao; Yujuan Zhou; Longzheng Xia; Deliang Cao
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Mechanisms and Treatment of Dyslipidemia in Diabetes.

Authors:  Ehete Bahiru; Ruth Hsiao; Daniel Phillipson; Karol E Watson
Journal:  Curr Cardiol Rep       Date:  2021-03-02       Impact factor: 2.931

Review 6.  The Role of Mitochondrial Adaptation and Metabolic Flexibility in the Pathophysiology of Obesity and Insulin Resistance: an Updated Overview.

Authors:  Dimitrios Tsilingiris; Evangelia Tzeravini; Chrysi Koliaki; Maria Dalamaga; Alexander Kokkinos
Journal:  Curr Obes Rep       Date:  2021-04-10

7.  Alterations of lipid metabolism, blood pressure and fatty liver in spontaneously hypertensive rats transgenic for human cholesteryl ester transfer protein.

Authors:  Yi-Qiang Liang; Masato Isono; Tadashi Okamura; Fumihiko Takeuchi; Norihiro Kato
Journal:  Hypertens Res       Date:  2020-01-24       Impact factor: 3.872

8.  Thioesterase Superfamily Member 2 Promotes Hepatic VLDL Secretion by Channeling Fatty Acids Into Triglyceride Biosynthesis.

Authors:  Michele Alves-Bezerra; Yingxia Li; Mariana Acuña; Anna A Ivanova; Kathleen E Corey; Eric A Ortlund; David E Cohen
Journal:  Hepatology       Date:  2019-03-22       Impact factor: 17.425

9.  β2-Adrenergic receptor agonist induced hepatic steatosis in mice: modeling nonalcoholic fatty liver disease in hyperadrenergic states.

Authors:  Yun Shi; Jason Pizzini; Hanzhou Wang; Falguni Das; Parveez Ahamed Abdul Azees; Goutam Ghosh Choudhury; Jeffrey L Barnes; Mengwei Zang; Susan T Weintraub; Chih-Ko Yeh; Michael S Katz; Amrita Kamat
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-05-24       Impact factor: 4.310

Review 10.  Lipid metabolism, inflammation, and foam cell formation in health and metabolic disorders: targeting mTORC1.

Authors:  So Yeong Cheon; KyoungJoo Cho
Journal:  J Mol Med (Berl)       Date:  2021-07-26       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.